ID   RAMP2_HUMAN             Reviewed;         175 AA.
AC   O60895; A7L9S6; K7EMD3; Q8N1F2;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2003, sequence version 2.
DT   07-APR-2021, entry version 178.
DE   RecName: Full=Receptor activity-modifying protein 2;
DE   AltName: Full=Calcitonin-receptor-like receptor activity-modifying protein 2;
DE            Short=CRLR activity-modifying protein 2;
DE   Flags: Precursor;
GN   Name=RAMP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Neuroblastoma;
RX   PubMed=9620797; DOI=10.1038/30666;
RA   McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N.,
RA   Solari R., Lee M.G., Foord S.M.;
RT   "RAMPs regulate the transport and ligand specificity of the calcitonin-
RT   receptor-like receptor.";
RL   Nature 393:333-339(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Rorabaugh B.R., Witt K.M., Smith D.D., Abel P.W., Scofield M.A.;
RT   "Characterization of adrenomedullin receptors and identification of a
RT   receptor activity modifying protein 2 (RAMP2) variant in SV40LT-SMC
RT   cells.";
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH CALCRL.
RX   PubMed=30115739; DOI=10.1084/jem.20180528;
RA   Mackie D.I., Al Mutairi F., Davis R.B., Kechele D.O., Nielsen N.R.,
RA   Snyder J.C., Caron M.G., Kliman H.J., Berg J.S., Simms J., Poyner D.R.,
RA   Caron K.M.;
RT   "hCALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with
RT   lymphatic dysplasia.";
RL   J. Exp. Med. 215:2339-2353(2018).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 48-139, AND DISULFIDE BONDS.
RG   Structural genomics consortium (SGC);
RT   "Structure of the extracellular domain of human RAMP2.";
RL   Submitted (DEC-2010) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 52-139 IN COMPLEX WITH CALCRL,
RP   FUNCTION, AND DISULFIDE BONDS.
RX   PubMed=22102369; DOI=10.1002/pro.2003;
RA   Kusano S., Kukimoto-Niino M., Hino N., Ohsawa N., Okuda K., Sakamoto K.,
RA   Shirouzu M., Shindo T., Yokoyama S.;
RT   "Structural basis for extracellular interactions between calcitonin
RT   receptor-like receptor and receptor activity-modifying protein 2 for
RT   adrenomedullin-specific binding.";
RL   Protein Sci. 21:199-210(2012).
CC   -!- FUNCTION: Transports the calcitonin gene-related peptide type 1
CC       receptor (CALCRL) to the plasma membrane. Acts as a receptor for
CC       adrenomedullin (AM) together with CALCRL. {ECO:0000269|PubMed:22102369,
CC       ECO:0000269|PubMed:9620797}.
CC   -!- SUBUNIT: Heterodimer of CALCRL and RAMP2.
CC       {ECO:0000269|PubMed:30115739}.
CC   -!- INTERACTION:
CC       O60895; Q16602: CALCRL; NbExp=6; IntAct=EBI-9009040, EBI-962878;
CC       O60895; Q9UHD4: CIDEB; NbExp=3; IntAct=EBI-9009040, EBI-7062247;
CC       O60895; P80188: LCN2; NbExp=3; IntAct=EBI-9009040, EBI-11911016;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60895-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60895-2; Sequence=VSP_055838;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in lung, breast, immune system
CC       and fetal tissues. {ECO:0000269|PubMed:9620797}.
CC   -!- SIMILARITY: Belongs to the RAMP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ001015; CAA04473.1; -; mRNA.
DR   EMBL; EF687002; ABS28868.1; -; mRNA.
DR   EMBL; AY265458; AAP23299.1; -; mRNA.
DR   EMBL; AC100793; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC027975; AAH27975.1; -; mRNA.
DR   CCDS; CCDS11437.1; -. [O60895-1]
DR   RefSeq; NP_005845.2; NM_005854.2. [O60895-1]
DR   PDB; 2XVT; X-ray; 2.05 A; A/B/C/D/E/F=48-139.
DR   PDB; 3AQE; X-ray; 2.00 A; A/B/C/D/E/F=56-139.
DR   PDB; 3AQF; X-ray; 2.60 A; A=56-139.
DR   PDB; 4RWF; X-ray; 1.76 A; A=55-138.
DR   PDB; 6UUN; EM; 3.00 A; E=44-175.
DR   PDB; 6V2E; X-ray; 1.83 A; A=55-140.
DR   PDBsum; 2XVT; -.
DR   PDBsum; 3AQE; -.
DR   PDBsum; 3AQF; -.
DR   PDBsum; 4RWF; -.
DR   PDBsum; 6UUN; -.
DR   PDBsum; 6V2E; -.
DR   SMR; O60895; -.
DR   BioGRID; 115557; 4.
DR   ComplexPortal; CPX-2191; Adrenomedullin receptor AM1 complex.
DR   ComplexPortal; CPX-3186; Amylin receptor 2 complex.
DR   CORUM; O60895; -.
DR   IntAct; O60895; 3.
DR   STRING; 9606.ENSP00000253796; -.
DR   BindingDB; O60895; -.
DR   ChEMBL; CHEMBL2109232; -.
DR   ChEMBL; CHEMBL2364173; -.
DR   DrugBank; DB01278; Pramlintide.
DR   DrugCentral; O60895; -.
DR   GuidetoPHARMACOLOGY; 52; -.
DR   TCDB; 8.A.127.1.2; the receptor activity-modifying protein (ramp) family.
DR   GlyGen; O60895; 1 site.
DR   PhosphoSitePlus; O60895; -.
DR   BioMuta; RAMP2; -.
DR   EPD; O60895; -.
DR   MassIVE; O60895; -.
DR   PaxDb; O60895; -.
DR   PeptideAtlas; O60895; -.
DR   PRIDE; O60895; -.
DR   ProteomicsDB; 49658; -. [O60895-1]
DR   Antibodypedia; 29403; 280 antibodies.
DR   DNASU; 10266; -.
DR   Ensembl; ENST00000253796; ENSP00000253796; ENSG00000131477. [O60895-1]
DR   Ensembl; ENST00000587142; ENSP00000466455; ENSG00000131477. [O60895-2]
DR   GeneID; 10266; -.
DR   KEGG; hsa:10266; -.
DR   UCSC; uc002ibg.5; human. [O60895-1]
DR   CTD; 10266; -.
DR   DisGeNET; 10266; -.
DR   GeneCards; RAMP2; -.
DR   HGNC; HGNC:9844; RAMP2.
DR   HPA; ENSG00000131477; Low tissue specificity.
DR   MIM; 605154; gene.
DR   neXtProt; NX_O60895; -.
DR   OpenTargets; ENSG00000131477; -.
DR   PharmGKB; PA34203; -.
DR   VEuPathDB; HostDB:ENSG00000131477.10; -.
DR   eggNOG; ENOG502S5WC; Eukaryota.
DR   GeneTree; ENSGT00940000160264; -.
DR   InParanoid; O60895; -.
DR   OMA; PNPWAEQ; -.
DR   PhylomeDB; O60895; -.
DR   TreeFam; TF333286; -.
DR   PathwayCommons; O60895; -.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-419812; Calcitonin-like ligand receptors.
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   BioGRID-ORCS; 10266; 8 hits in 985 CRISPR screens.
DR   ChiTaRS; RAMP2; human.
DR   GeneWiki; RAMP2; -.
DR   GenomeRNAi; 10266; -.
DR   Pharos; O60895; Tclin.
DR   PRO; PR:O60895; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; O60895; protein.
DR   Bgee; ENSG00000131477; Expressed in right lung and 183 other tissues.
DR   ExpressionAtlas; O60895; baseline and differential.
DR   Genevisible; O60895; HS.
DR   GO; GO:1903143; C:adrenomedullin receptor complex; IDA:UniProtKB.
DR   GO; GO:0150057; C:amylin receptor complex 2; IDA:ARUK-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; TAS:ProtInc.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:UniProtKB.
DR   GO; GO:1990409; F:adrenomedullin binding; IPI:UniProtKB.
DR   GO; GO:0001605; F:adrenomedullin receptor activity; IPI:UniProtKB.
DR   GO; GO:0015026; F:coreceptor activity; ISS:UniProtKB.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0034333; P:adherens junction assembly; IDA:UniProtKB.
DR   GO; GO:1990410; P:adrenomedullin receptor signaling pathway; IPI:UniProtKB.
DR   GO; GO:0097647; P:amylin receptor signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0001525; P:angiogenesis; IDA:UniProtKB.
DR   GO; GO:0070831; P:basement membrane assembly; ISS:UniProtKB.
DR   GO; GO:0070830; P:bicellular tight junction assembly; IDA:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IBA:GO_Central.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:UniProtKB.
DR   GO; GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; TAS:Reactome.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; IDA:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:2001214; P:positive regulation of vasculogenesis; IEA:Ensembl.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IDA:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; ISS:UniProtKB.
DR   GO; GO:0008277; P:regulation of G protein-coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0097084; P:vascular associated smooth muscle cell development; ISS:UniProtKB.
DR   GO; GO:0001570; P:vasculogenesis; IMP:UniProtKB.
DR   Gene3D; 1.10.150.510; -; 1.
DR   InterPro; IPR006985; RAMP.
DR   InterPro; IPR038126; RAMP_sf.
DR   PANTHER; PTHR14076; PTHR14076; 1.
DR   Pfam; PF04901; RAMP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein; Membrane;
KW   Receptor; Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL          1..42
FT                   /evidence="ECO:0000255"
FT   CHAIN           43..175
FT                   /note="Receptor activity-modifying protein 2"
FT                   /id="PRO_0000030172"
FT   TOPO_DOM        43..145
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        146..166
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        167..175
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        130
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        68..99
FT   DISULFID        84..131
FT   VAR_SEQ         54
FT                   /note="E -> EASVPT (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_055838"
FT   CONFLICT        13
FT                   /note="R -> C (in Ref. 2; ABS28868)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        25
FT                   /note="L -> V (in Ref. 1; CAA04473)"
FT                   /evidence="ECO:0000305"
FT   HELIX           49..54
FT                   /evidence="ECO:0007744|PDB:4RWF"
FT   HELIX           61..76
FT                   /evidence="ECO:0007744|PDB:4RWF"
FT   HELIX           77..82
FT                   /evidence="ECO:0007744|PDB:4RWF"
FT   HELIX           86..106
FT                   /evidence="ECO:0007744|PDB:4RWF"
FT   HELIX           114..126
FT                   /evidence="ECO:0007744|PDB:4RWF"
FT   TURN            127..130
FT                   /evidence="ECO:0007744|PDB:3AQE"
FT   HELIX           143..154
FT                   /evidence="ECO:0007744|PDB:6UUN"
FT   HELIX           157..166
FT                   /evidence="ECO:0007744|PDB:6UUN"
SQ   SEQUENCE   175 AA;  19608 MW;  AF69A9A461EFFCA3 CRC64;
     MASLRVERAG GPRLPRTRVG RPAALRLLLL LGAVLNPHEA LAQPLPTTGT PGSEGGTVKN
     YETAVQFCWN HYKDQMDPIE KDWCDWAMIS RPYSTLRDCL EHFAELFDLG FPNPLAERII
     FETHQIHFAN CSLVQPTFSD PPEDVLLAMI IAPICLIPFL ITLVVWRSKD SEAQA
//
